Persistent infection and vascular disease: a systematic review

Bibliography

• FABRICANT CG, FABRICANT J, LITRENTA MM, MINICK CR: Virus-induced atherosclerosis. J. Exp. Med. (1978) 148:335–340.
   PubMed Web of Science ®Google Scholar
• •Report of experiments in chickens that led to the search for infective agents in human vascular disease.
   Google Scholar
• LIBBY P, EGAN D, SKARLATOS S: Roles of infectiousagents in atherosclerosis and restenosis: an assess-ment of the evidence and need for future research. Cir-culation (1997) 96:4095–4103.
   PubMed Web of Science ®Google Scholar
• COOK PJ, LIP GYH: Infectious agents and atheroscle-rotic vascular disease. Quart. J. Med. (1996) 89:727–735.
   Google Scholar
• MELNICK JL, ADAM E, DEBAKEY ME: Possible role of cy-tomegalovirus in atherogenesis. JAMA (1990) 263:2204–2207.
   PubMed Web of Science ®Google Scholar
• ADAM E, MELNICK JL, DEBAKEY ME: Cytomegalovirusinfection and atherosclerosis. Cent. Eur. J. Public Health (1997) 5:99–106.
   PubMedGoogle Scholar
• SAIKKU P: Chlamydia pneumoniae and atherosclerosis- an update. Scand. J. Infect. Dis. (1997) 104 (Suppl.):53–56.
   Google Scholar
• GRAYSTON JT: Chlamydia pneumoniae and atheroscle-rosis. Rev. Med. Intern. (1996) 17 (Suppl. 1):45s–47s.
   Google Scholar
• GUPTA S, CAMM AJ: Chronic infection in the etiology ofatherosclerosis - the case for Chlamydia pneumoniae. Clin. Cardiol. (1997) 20:829–836.
   PubMed Web of Science ®Google Scholar
• COLES KA, PLANT AJ, RILEY TV, SMITH DW: Cardiovascu-lar disease: an infectious aetiology? Rev. Med. Microbiol (1998) 9:17–27.
   Google Scholar
• SHARFAN SD, CONLY JM: Does Chlamydia pneumoniae cause coronary atherosclerosis and should we all take macrolides? Can. J. Infect. Dis. (1997) 8:249–251.
   Google Scholar
• GUPTA S, CAMM AJ: Chlamydia pneumoniae and coro-nary heart disease. Br. Med. J. (1997) 314:1778–1779.
   PubMed Web of Science ®Google Scholar
• GUPTA S, LEATHAM EW: The relation between Chlamy-dia pneumoniae and atherosclerosis. Heart (1997) 77:7–8.
   PubMed Web of Science ®Google Scholar
• GAYDOS CA: Chlamydia pneumoniae: a review andevidence for a role in coronary artery disease. Clin. Mi-crobiol. Newslett. (1995) 17:49–56.
   Google Scholar
• GRAYSTON JT, KUO CC, CAMPBELL LA, BENDITT EP: Chlamydia pneumoniae, strain TWAR and atheroscle-rosis. Eur. Heart J. (1993) 14 (Suppl. K):66–71.
   Google Scholar
• SAIKKU P: Chlamydia pneumoniae infection as a risk factor in acute myocardial infarction. Eur. Heart J. (1993) 14(Suppl. K):62–65.
   Google Scholar
• CAPRON L: Chlamydia in coronary plaques - hidden culprit or harmless hobo? Nature Med. (1996) 2:856–857.
   Google Scholar
• BURCH GE: Viruses and arteriosclerosis. Am. Heart J. (1974) 87:407–412.
   PubMed Web of Science ®Google Scholar
• BECK J, GARCIA R, HEISS G, VOKONAS PS, OFFEN-BACHER S: Periodontal disease and cardiovascular dis-ease. J. Periodontol. (1996) 67:1123–1137.
   PubMed Web of Science ®Google Scholar
• SEYMOUR RA, STEELE JG: Is there a link between perio-dontal disease and coronary heart disease? Br. Dent. J. (1998) 184:33–38.
   Google Scholar
• LOESCHE WJ: Periodontal disease as a risk factor forheart disease. Compen. Contin. Educ. Dent. (1994) 15:976–992.
   Google Scholar
• MATTILA KJ: Dental infections as a risk factor for acute myocardial infarction. Eur. Heart J. (1993) 14 (Suppl. K):51–53.
   Google Scholar
• GUPTA S, KASKI JC, CAMM AJ: Antibiotic therapy in coronary heart disease: hype versus hope. Br. J. Car-diol. (1998) 5:65-66. DANESH J, COLLINS R, PETO R: Chronic infections and coronary heart disease: is there a link? Lancet (1997) 350:430-436. First attempt to review systematically the available evidence on chronic infection and coronary heart disease. BAINTON D, JONES GR, HOLE D: Influenza and ischae-mic heart disease - a possible trigger for acute myocar-dial infarction? Int. J. Epidemic)]. (1978) 7:231–239.
   Google Scholar
• EICKHOFF TC, SHERMAN IL, SERFLING RE: Observations on excess mortality associated with epidemic influ-enza. JAMA (1961) 176:776–782.
   PubMed Web of Science ®Google Scholar
• BABOONIAN C, TREASURE T: Meta-analysis of the asso-ciation of enteroviruses with human heart disease. Heart (1997) 78:539–543.
   PubMed Web of Science ®Google Scholar
• NIKOSKELAINEN J, KALLIOMAKI JL, LAPINLEIMU K et al:Virus antibodies in myocardial infarction. Acta Med. Scand. (1983) 214:29–32.
   PubMed Web of Science ®Google Scholar
• NICHOLLS AC, THOMAS M: Coxsackie virus infection in acute myocardial infarction. Lancet (1977) i:883–885.
   Google Scholar
• GRIFFITHS PD, HANNINGTON G, BOOTH JC: Coxsackie B virus infections and myocardial infarction. Lancet (1980) i:1387–1389.
   Google Scholar
• GRAU AJ, BUGGIE F, HEINDL S et al: Recent infection asa risk factor for cerebrovascular ischemia. Stroke (1995) 26:373–379.
   PubMed Web of Science ®Google Scholar
• MATTILA KJ: Viral and bacterial infections in patientswith acute myocardial infarction. J. Intern. Med. (1989) 225:293–296.
   PubMed Web of Science ®Google Scholar
• SPODICK DH, FLESSAS AP, JOHNSON MM: Association ofacute respiratory symptoms with onset of acute myo-cardial infarction: prospective investigation of 150 consecutive patients and matched control patients. Am. J. Cardiol. (1984) 53:481–482.
   PubMed Web of Science ®Google Scholar
• SYRJAENEN J, VALTONEN VV, IIVANAINEN M, KASTE M,HUTTUNEN JK: Preceding infection as an important risk factor for ischaemic brain infarction in young and middle-aged patients. Br. Med. J. (1988) 296:1156–1160.
   PubMed Web of Science ®Google Scholar
• FELDMAN RA, EVANS SJW: Accuracy of diagnostic meth-ods used for epidemiological studies of Helicobacter pylori Aliment. Pharmacol. Ther. (1995) 9\(Suppl. 2):21–31.
   Google Scholar
• KOSUNEN TU, AROMAA A, KNEKT P et al: Helicobacterantibodies in 1973 and 1994 in the adult population of Vammala, Finland. Epidemiol Infect. (1997) 119:29–34.
   PubMed Web of Science ®Google Scholar
• ROSENSTOCK SJ, ANDERSEN LP, BONNEVIE 0, JOR-GENSEN T: Sero-conversion and sero-reversion in IgG antibodies to H. pylori: an 11-year follow-up of 2,523 randomly selected Danes. Gut (1996) 39\(Suppl. 3). Ab-stract A3.
   Google Scholar
• PETO R: Two properties of multiple regression analy-sis) and regression to the mean (and regression from the mean). In: The Natural History of Chronic Bronchitis and Emphysema. An Eight Year Study of Early Chronic Ob-structive Lung Disease in Working Men in London. Fletcher CM, Peto R, Tinker CM, Speizer FE, (Eds.), Oxford University Press, Oxford (1976):218–223.
   Google Scholar
• BOZOVICH GE, GURFINKEL EP: Chlamydia pneumo-niae: more than a bystander in acute coronary syn-dromes. Br. J. Cardiol (1998) 5:84–90.
   Google Scholar
• GILL EA, MCINTYRE TM, PRESCOTT SM, ZIMMERMAN GA:Mechanisms of vascular injury in the pathogenesis of infectious disease. Curr. Opin. Infect. Dis. (1992) 5:381–388.
   Web of Science ®Google Scholar
• VALLANCE P, COLLIER J, BHAGAT K: Infection, inflam-mation, and infarction: does acute endothelial dys-function provide a link? Lancet (1997) 349:1391–1392.
   PubMed Web of Science ®Google Scholar
• LEINONEN M: Pathogenetic mechanisms and epidemi-ology of Chlamydia pneumoniae. Eur. Heart J. (1993) 14 (Suppl. K):57–61.
   Google Scholar
• EPSTEIN SE, SPEIR E, ZHOU YF et al.: The role of infec-tion in restenosis and atherosclerosis: focus on cy-tomegalovirus. Lancet (1996) 348 (Suppl. D:s13–s17.
   Google Scholar
• PATEL P, MENDALL MA, CARRINGTON D et al.: Associa-tion of Helicobacter pylori and Chlamydia pneumo-niae infections with coronary heart disease and cardiovascular risk factors. Br. Med. J. (1995) 311:711–714.
   PubMed Web of Science ®Google Scholar
• MENDALL MA, PATEL P, BALLAM L, STRACHAN D, NORTHFIELD TC: C-reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study. Br. Med. J. (1996) 312:1061–1065.
   PubMed Web of Science ®Google Scholar
• RIDKER PM, CUSHMAN M, STAMPFER MJ, TRACY RP, HEN-NEKENS CH: Inflammation, aspirin, and the risk of car-diovascular disease in apparently healthy men. New Engl. J. Med. (1997) 336:973–979.
   PubMed Web of Science ®Google Scholar
• BIRNIE D, MCKAY IC, HOOD S, MCCOLL KEJ, HILLIS WS: Association between antibodies to mycobacterial heat shock protein 65 and coronary atherosclerosis: possi-ble mechanism of action of Helicobacter pylori in in-creasing cardiovascular risk. Eur. Heart J. (1998) 19:387–394.
   PubMed Web of Science ®Google Scholar
• WHINCUP PH, MENDALL MA, PERRY IJ, STRACHAN DP, WALKER M: Prospective relations between Helicobac-ter pylori infection, coronary heart disease, and stroke in middle-aged men. Heart (1996) 75:568–572.
   PubMed Web of Science ®Google Scholar
• MURRAY LJ, BAMFORD KB, O'REILLY DPJ, MCCRUM EE, EVANS AE: Helicobacter pyloriinfection: relation with cardiovascular risk factors, ischaemic heart disease, and social class. Br. Heart J. (1995) 74:497–501.
   PubMedGoogle Scholar
• NIEMELA S, KARTTUNEN T, KORHONEN T et al.: Could Helicobacterpyloriinfection increase the risk of coro-nary heart disease by modifying serum lipid concen-trations? Heart (1996) 75:573–575.
   Google Scholar
• RATHBONE BJ, MARTIN D, STEPHENS J, THOMPSON JR, SAMANI NJ: Helicobacter pylori infection does not in-fluence the risk of acute myocardial infarction. Heart (1996) 76:308–311.
   PubMed Web of Science ®Google Scholar
• SCRAGG RKR, FRASER A, METCALF PA: Helicobacter py-lori seropositivity and cardiovascular risk factors in a multicultural workforce. J. Epidemiol. Commun. Health (1996) 50:578–579.
   PubMed Web of Science ®Google Scholar
• MCDONAGH TA, WOODWARD M, MORRISON C et al.: Lack of independent association of H. pylori and coro-nary heart disease. Eur. Heart J. (1997) 18:1257–1260.
   Google Scholar
• GERNING NO, MOAYYEDI P, AXON ATR, GRANT PJ: The association between Helicobacter pylori and ischae-mic heart disease assessed by coronary angiography. Cardiovasc. Res. (1997) 35:120–124.
   PubMedGoogle Scholar
• CARTER AN, MOAYYEDI P, CATTO A eta].: The influenceof Helicobacter pylori status on circulating levels of the coagulation factors fibrinogen, von Willebrand factor, factor VII, and factor VIII. Helicobacter (1996) 1:65-69. © Ashley Publications Ltd. All rights reserved.Exp. Opin. Invest. Drugs (1998) 7(5)
   Google Scholar
• PATEL P, CARRINGTON D, STRACHAN DP et al.: Fibrino-gen: a link between chronic infection and coronary heart disease. Lancet (1994) 343:1634–1635.
   PubMed Web of Science ®Google Scholar
• SUNG BY, SANDERSON JE: Hyperhomocysteinaemia, Helicobacter pylori, and coronary heart disease. Heart (1996) 76:305–307.
   PubMed Web of Science ®Google Scholar
• LANGMAN M, COOKE A.: Gastric and duodenal ulcerand their associated diseases. Lancet (1976) i:680–683.
   Google Scholar
• WALD NJ, LAW MR, MORRIS JK, BAGNALL AM: Helicobac-ter pylori infection and mortality from ischaemic heart disease: negative result from a large, prospective study. Br. Med. J. (1997) 315:1199–1201.
   PubMed Web of Science ®Google Scholar
• •Large epidemiological study in a socially homogeneous population that argues against strong correlations in men in late middle-age.
   Google Scholar
• AROMAA A, KNEKT P, REUNANEN A, RAUTELIN HI, KOSUNEN TU: Helicobacter pyloriand the risk of myo-cardial infarction. Gut (1996) 39 (Suppl. 2) :A91.
   Google Scholar
• BUFFON A, LIUZZO GM, CALIGIURI G et al.: Associationbetween prior Helicobacter pylori infection and the risk of restenosis after coronary angioplasty. Circula-tion (1997) 96(Suppl.
   Google Scholar
• FOLSOM AR, NIETO FJ, SORLIE P, CHAMBLESS LE, GRA-HAM DY: No association of Helicobacter pylori sero-positivity with coronary heart disease in a prospective study. Circulation (1997) 96 (Suppl. J–100.
   Google Scholar
• STRANDBERG TE, TILVIS RS, VUORISTO M, KOSUNEN TU:H. pylori infection and cardiovascular diseases in eld-erly population. Br. Med. J. (1997) 314:1317–1318.
   Google Scholar
• MENDALL MA, GOGGIN PM, MOLINEAUX N et al.: Rela-tion of Helicobacter pylori infection and coronary heart disease. Br. Heart J. (1994) 71:437–439.
   PubMedGoogle Scholar
• PASCERI V, PATTI G, CAMMAROTA G et al.: Associationof cytotoxin-associated gene A Helicobacter pylori with ischemic heart disease. Circulation (1997) 96:1.
   Google Scholar
• BALABAN DH, PEURA DA, WATSON D, REMBOLD C, SHIFFLETT J: Relationship between H. pylori infection and ischemic heart disease. Gastroenterology (1996) 110:A55
   Google Scholar
• VAKIL N, KHURSHID A, FENSKE T, BAJWA T: H. pylori in-fection in patients with and without coronary artery disease. Gut (1996) 39 (Suppl. 2) :A91.
   Google Scholar
• MAIER F, AURICCHIO A, NILIUS M, KLEIN P, MALFERTHEI-NER P: Lack of association between Helicobacter py-lori infection and angiographically documented coronary heart disease. Gastroenterology (1996) 110:A183.
   Google Scholar
• CASELLI M, KUBBAJEH M, RUINA M et al.: Helicobacterpylori and heart. Gut (1996) 39 (Suppl. 2) :A91.
   Google Scholar
• ACETI A, MAZZACURATI G, AMENDOLEA MA, PENNICAA, ZECHINI B: H. pylori and C. pneumoniae infections may account for most acute coronary syndromes. Br. Med. J. (1996) 313:428–429.
   Google Scholar
• MARTIN-DE-ARGILA C, BOIXEDA D, CANTON R, GISBERTJP, FUERTES A: High seroprevalence of Helicobacter pylori infection in coronary heart disease. Lancet (1995) 346:310.
   PubMed Web of Science ®Google Scholar
• QUINN MJ, FOLEY B, LEE J etal.: Helicobacter pylori and angiographically documented coronary artery dis-ease. Circulation (1997) 96 (Suppl. D:1–342.
   Google Scholar
• MALNICK SDH, ADLAN K, GOLAND S et al.: High inci-dence of H. pylori in young patients with coronary ar-tery disease. Gut (1996) 39\(Suppl. 3):A63.
   Google Scholar
• MORGANDO A, SANSEVERINO P, PEROTTO C et at: Heli-cobacter pylori seropositivity in myocardial infarc-tion. Lancet (1995) 345:1380.
   PubMed Web of Science ®Google Scholar
• PONZETTO A, LA ROVERE MT, SANSEVERINO P, BAZZOLI F: Association of Helicobacter pylori infection with coronary heart disease. Br. Med. J. (1996) 312:251.
   PubMed Web of Science ®Google Scholar
• MENDALL MA, GOGGIN PM, MOLINEAUX N et al.: Child-hood living conditions and Helicobacter pylori sero-positivity in adult life. Lancet (1992) 339:896–897.
   PubMed Web of Science ®Google Scholar
• GLYNN JR: Helicobacter pylori and the heart. Lancet (1994) 344:146.
   PubMed Web of Science ®Google Scholar
• COLIN-JONES DG, LANGMAN MJS, LAWSON DH: Post-marketing surveillance of the safety of cimetidine: 10 year mortality report. Gut (1992) 33:1280–1284.
   PubMed Web of Science ®Google Scholar
• DANESH JN, PETO R: Risk factors for coronary heart disease and infection with Helicobacter pylori: meta-analysis of 18 studies. Br. Med. J. (1998) 316:1130–1132.
   PubMed Web of Science ®Google Scholar
• BLASI F, DENTI F, ERBA M et al.: Detection of Chlamydia pneumoniae but not Helicobacter pyloriin atheroscle-rotic plaques of aortic aneurysms. J. Clin. Micr. (1996) 34:2766–2769.
   PubMed Web of Science ®Google Scholar
• MARKLE HV: Coronary artery disease associated with Helicobacter pyloriinfection is at least partially due to inadequate folate status. Med. Hypoth. (1997) 49:289–292.
   PubMed Web of Science ®Google Scholar
• KARK JD, LEIONEN M, PALTIEL 0: Chlamydia pneumo-niae and acute myocardial infarction in Jerusalem. mt. J. Epidemic)]. (1997) 4:730–738.
   Google Scholar
• MIETTINEN H, LEHTO S, SAIKKU P et al.: Association of Chlamydia pneumoniae and acute coronary heart dis-ease events in non-insulin dependent diabetic and non-diabetic subjects in Finland. Eur. Heart J. (1996) 17:682–688.
   PubMed Web of Science ®Google Scholar
• SAIKKU P, LEINONEN M, TENKANEN L et al.: Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study. Ann. Intern. Med. (1992) 116:273–278.
   PubMed Web of Science ®Google Scholar
• CARLSSON J, MIKETIC S, MUELLER KH et al.: Previous cy-tomegalovirus or Chlamydia pneumoniae infection and risk of restenosis after percutaneous transluminal coronary angioplasty. Lancet (1997) 350:1225.
   PubMed Web of Science ®Google Scholar
• OSSEWARDE JM, VALLINGA C, FESKENS EJM, KROM-HOUT D: Infection with Chlamydia pneumoniae as a risk factor for coronary heart disease (the Zutphen elderly study). Atherosclerosis (1995) 115 (Suppl.) :S13. Ab-stract.
   Google Scholar
• MELNICK SL, SHAHAR E, FOLSOM AR eta].:Past infection by Chlamydia pneumoniae strain TWAR and © Ashley Publications Ltd. All rights reserved.Exp. Opin. Invest. Drugs (1998) 7(5) asymptomatic carotid atherosclerosis. Am. J. Med. (1993) 95:499–504.
   Google Scholar
• THOM DH, GRAYSTON JY, SISCOVICK DS et al.: Associa-tion of prior infection with Chlamydia pneumoniae and angiographically demonstrated coronary artery disease. JAMA (1992) 268:68–72.
   PubMed Web of Science ®Google Scholar
• DAHLEN GH, BOMAN J, BIRGANDER LS, LINDBLOM B:Lp (a) lipoprotein, IgG, IgA and IgM antibodies to Chia-mydia pneumoniae and HLA class II genotype in early coronary artery disease. Atherosclerosis (1995) 114:165–174.
   PubMed Web of Science ®Google Scholar
• SAIKKU P, MATTILA K, NIEMINEN MS et al.: Serologicalevidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet (1988) 2:983–986.
   PubMed Web of Science ®Google Scholar
• LEINONEN M, LINNANMAKI E, MATTILA K et al.: Circulat-ing immune complexes containing chlamydial lipo-polysaccharide in acute myocardial infarction. Microb. Pathogen. (1990) 9:67–73.
   PubMed Web of Science ®Google Scholar
• LINNANMAKI E, LEINONEN M, MATTILA K et al.: Chlamy-dia pneumoniae - specific circulating immune com-plexes in patients with chronic coronary heart disease. Circulation (1993) 87:1130–1134.
   PubMed Web of Science ®Google Scholar
• HAIDL S, MOLLER SJ, ISRAELSSON B, PERSSON K:Ischemic heart disease and antibodies to Chlamydia pneumoniae (TWAR). Proc. Sym. Eur. Soc. Chlamydia Res. (1992) 2:174.
   Google Scholar
• MENDALL MA, CARRINGTON D, STRACHAN D et al.: Chia-mydia pneumoniae: risk factors for seropositivity and association with coronary heart disease. J. Infect. (1995) 30:121–128.
   PubMed Web of Science ®Google Scholar
• WEISS SM, ROBLIN PM, GAYDOS CA et al: Failure to de-tect Chlamydia pneumoniae in coronary atheromas of patients undergoing atherectomy. J. Infect. Dis. (1996) 173:957–963.
   PubMed Web of Science ®Google Scholar
• BLASI F, COSENTINI R, RACCANELLI R eta].: A possible as-sociation of Chlamydia pneumoniae infection and acute myocardial infarction in patients younger than 65 years of age. Chest (1997) 112:309–312.
   Google Scholar
• WIMMER MU, SANDMAN-STRUPP R, SAIKKU P, HABERL RL: Association of chlamydial infection with cerebro-vascular disease. Stroke (1996) 27:2207–2210.
   PubMed Web of Science ®Google Scholar
• THOM DH, WANG SP, GRAYSTON JT et al.: Chlamydia pneumoniae strain TWAR antibody and angiographi-rally demonstrated coronary artery disease. Arterio-scler. Thromb. (1991) 11:547–551.
   PubMedGoogle Scholar
• COOK PJ, LIP GYH, WISER: Chlamydia pneumoniae and acute arterial thrombotic disease. Circulation (1995) 92:3148–3149.
   PubMed Web of Science ®Google Scholar
• GIEFFERS J, MAASS M: Serological response to Chlamy-dia pneumoniae in coronary heart disease. 7th ECCMID (1995) 495. Abstract 95.
   Google Scholar
• POURNARAS G, PERDIKARIS G, MENTIS A et al Associa- tion of chronic Chlamydia pneumoniae infection with chronic coronary heart disease and acute myocardial infarction in Greece. 4th Int. Conf Macro. (1998). Abstract 4.11.
   Google Scholar
• WANG SP, GRAYSTON JT: Microimmunofluorescence serology in Chlamydia trachomatis. In: The 1983 Inter-national Symposium on Medical Virology de la Maza LM (Ed.), Elsevier Science Publishing Co. Inc., New York, NY (198087–118.
   Google Scholar
• COLLINS R, PETO R, GRAY R, PARISH S: Large-scale ran-domized evidence: trials and overviews. In: Textbook of Medicine. Weatherall D, Ledingham JGG, Warrell DA (Eds.), Oxford University Press, Oxford (1996)21–32.
   Google Scholar
• EASTERBROOK P, BERLIN J, GOPALAN R, MATTHEWS D: Publication bias in clinical research. Lancet (1991) 337:867–872.
   PubMed Web of Science ®Google Scholar
• LAURILA A, BLOIGU A, NAYHA S, HASSI J, LEINONEN M: Chlamydia pneumoniae antibodies and serum lipids in Finnish men: cross sectional study. Br. Med. J. (1997) 314:1456–1457.
   PubMed Web of Science ®Google Scholar
• LAURILA A, BLOIGU A, NAYHA S et al.: Chronic Chlamy-dia pneumoniae infection is associated with a serum lipid profile known to be a risk factor for atherosclero-sis. Arterioscler. Thromb. Vasc. Biol. (1997) 17:2910–2913.
   PubMed Web of Science ®Google Scholar
• GAYDOS CA, SUMMERSGILL JT, SAHNEY NN, RAMIREZ JA, QUINN TC: Replication of Chlamydia pneumoniae in vitro in human macrophages, endothelial cells, and aortic artery smooth muscle cells. Infect. Immun. (1996) 64:1614–1620.
   PubMed Web of Science ®Google Scholar
• CAMPBELL LA, MOAZED TC, KUO CC, GRAYSTON JT: Mouse models of atherosclerosis and Chlamydia pneumoniae. Proc. Third Eur. Soc. Chlam. Res. (1996) 3:106. Abstract.
   Google Scholar
• MUHLESTEIN JB, ANDERSON JL, HAMMOND EH et al.: In-fection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model. Circulation (1998) 96:633–636.
   Google Scholar
• MAASS M, GIEFFERS J: Prominent serological response to Chlamydia pneumoniae in cardiovascular disease. Immunol. Infect. (1996) 6:65–70.
   Google Scholar
• MUHLESTEIN JB, HAMMOND EH, CARLQUIST JF et al.: In-creased incidence of Chlamydia species within the coronary arteries of patients with symptomatic athe-rosclerotic versus other forms of cardiovascular dis-ease. J. Am. Coll. Cardiol. (1996) 27:1555–1561.
   PubMed Web of Science ®Google Scholar
• CHIU B, VIIRA E, TUCKER W, FONG IW: Chlamydia pneu-moniae, cytomegalovirus, and herpes simplex virus in atherosclerosis of the carotid artery. Circulation (1997) 96:2144–2148.
   PubMed Web of Science ®Google Scholar
• GRAYSTON JT, KUO CC, COULSON AS et al.: Chlamydia pneumoniae (TWAR) in atherosclerosis of the carotid artery [see comments]. Circulation (1995) 92:3397–3400.
   PubMed Web of Science ®Google Scholar
• MAASS M, KRAUSE E, ENGEL PM, KRUGER S: Endovascu-lar presence of Chlamydia pneumoniae in patients with hemodynamically effective carotid artery steno-sis. Angiology (1997) 48:699-706. © Ashley Publications Ltd. All rights reserved.Exp. Opin. Invest. Drugs (1998) 7(5)
   Google Scholar
• DAVIDSON M, KUO CC, MIDDAUGH JP et al.: Chlamydia pneumoniae (TWAR) in Alaska natives with coronary atheroma. Gun. Infect. Dis. (1995) 21:726.
   Google Scholar
• ENZLER MJ, SMITH TF, ESPY M et al.: Inability to detect Chlamydia pneumoniae (TWAR) in human autopsy coronary arteries by polymerase chain reaction. 35th ICAAC (1995). Abstract LM81.
   Google Scholar
• PUOLAKKAINEN M, KUO CC, SHOR A et al.: Serological response to Chlamydia pneumoniae in adults with coronary arterial fatty streaks and fibrolipid plaques. Clin. Micro]: (1993) 31:2212–2214.
   PubMed Web of Science ®Google Scholar
• VARGHESE PJ, GAYDOS CA, ARUMUGHAN SB etal.: Dem-onstration of Chlamydia pneumoniae in coronary atheroma specimens from young patients with nor-mal cholesterol from the southern part of India. Clin. Infect. Dis. (1995) 2:728.
   Google Scholar
• KUO CC, COULSON AS, CAMPBELL LA et al.: Detection of Chlamydia pneumoniae in atherosclerotic plaques in the walls of arteries of lower extremities from patients undergoing bypass operation for arterial obstruction. Vasc. Surg. (1997) 26:29–31.
   Google Scholar
• OUCHI K, FUJI B, KANAMOTO Y, MIYAZAKI H, NAKA-ZAWA T: Detection of Chlamydia pneumoniae in athe-rosclerotic lesions of coronary arteries and large arteries. 35th ICAAC (1995). Abstract K37.
   Google Scholar
• CAMPBELL LA, O'BRIEN ER, CAPPUCCIO AL et al.: Detec-tion of Chlamydia pneumoniae TWAR in human coro-nary atherectomy tissues. J. Infect. Dis. (1995) 172:585–588.
   Google Scholar
• KUO C, SHOR A, CAMPBELL L et al.: Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries. J. Infect. Dis. (1993) 167:841–849.
   PubMed Web of Science ®Google Scholar
• ONG G, THOMAS BJ, MANSFIELD AO, DAVIDSON BR, TAYLOR-ROBINSON D: Detection and widespread dis-tribution of Chlamydia pneumoniae in the vascular system and its possible implications. J. Clin. Pathol. (1996) 49:102–106.
   PubMed Web of Science ®Google Scholar
• JACKSON LA, CAMPBELL LA, SCHMIDT RA et al.: Specific-ity of detection of Chlamydia pneumoniae in cardio-vascular atheroma. Am. J. Pathol (1997) 150:1785–1790.
   PubMed Web of Science ®Google Scholar
• ONG G, THOMAS B, MANSFIELD AO et al.: Chlamydia pneumoniae in vascular tissue. Proc. Third Meeting Eur. Soc. Chlam. Res. (1996) 3:222.
   Google Scholar
• KUO CC, GOWN AM, BENDITT EP, GRAYSTON JT: Detec-tion of Chlamydia pneumoniae in aortic lesions of atherosclerosis by immunocytochemical stain. Arterio-scler. Thromb. (1993) 13:1501–1504.
   PubMed Web of Science ®Google Scholar
• •Unlike most other pathological studies, this report involved age-matched and sex-matched individuals who provided the control vascular tissue.
   Google Scholar
• KUO CC, GRAYSTON JT, CAMPBELL LA etal.: Chlamydia pneumoniae (TWAR) in coronary arteries of young adults (15–34 years old). Proc. Natl. Acad. ScL USA (1995) 92:6911–6914.
   Google Scholar
• CUNNINGHAM A, MATTHEWS R, ELLIS R, WARD ME: Di-rect demonstration of Chlamydia pneumoniae and Helicobacter pylori in coronary heart disease. (1996) 3:219. Abstract.
   Google Scholar
• SHOR A, KUO CC, PATTON DL: Detection of Chlamydia pneumoniae in coronary arterial fatty streaks and atheromatous plaques. S. Afr. Med. J. (1992) 82:158–161.
   PubMed Web of Science ®Google Scholar
• RAMIREZ JA: Isolation of Chlamydia pneumoniae from the coronary artery of a patient with coronary athero-sclerosis. Ann. Intern. Med. (1996) 125:979–982.
   PubMed Web of Science ®Google Scholar
• •Culture of the organism from blood vessel lesions provided more direct evidence of the possible relevance of the infec-tion to disease than previous studies of markers.
   Google Scholar
• JACKSON LA, CAMPBELL LA, KUO CC et al.: Isolation of Chlamydia pneumoniae from a carotid endarterec-tomy specimen. J. Infect. Dis. (1997) 176:292–295.
   PubMed Web of Science ®Google Scholar
• JUVONEN J, LAURILA A, JUVONEN T et al.: Detection of Chlamydia pneumoniae in human non-rheumatic stenotic aortic valves. Proc. Third Meeting Eur. Soc. Chlam. Res. (1996) 3:221. Abstract.
   Google Scholar
• DESTEFANO F, ANDA RF, KAHN HS, WILLIAMSON DF, RUSSELL CM: Dental disease and risk of coronary heart disease and mortality. Br. Med. J. (1993) 306:688–691.
   PubMed Web of Science ®Google Scholar
• MATTILA KJ, VALTONEN W, NIEMINEN M, HUTTUNEN JK: Dental infection and the risk of new coronary events: prospective study of patients with documented coronary artery disease. Clin. Infect. Dis. (1995) 20:588–592.
   PubMed Web of Science ®Google Scholar
• JOSHIPURA KJ, RIMM EB, DOUGLASS CW et al: Poor oral health and coronary heart disease. J. Dent. Res. (1996) 75:1631–1636.
   PubMed Web of Science ®Google Scholar
• GENCO R, CHADDA S, GROSSI S et al.: Periodontal dis-ease is a predictor of cardiovascular disease in a Native American population. J. Dent. Res. (1997) 76. Abstract 3158.
   Google Scholar
• MATTILA KJ, VALLE MS, NIEMINEN MS, VALTONEN VV, HIETANIEMI KL: Dental infections and coronary athe-rosclerosis. Atherosclerosis (1996) 103:205–211.
   Google Scholar
• PAUNIO K, IMPIVAARA 0, TIEKSO J, MAKI J: Missing teeth and ischaemic heart disease in men aged 45-64 years. Eur. Heart J. (1993) 14:54–56.
   PubMed Web of Science ®Google Scholar
• MATTILA KJ, NIEMINEN MS, VALTONEN W et al: Associa-tion between dental health and acute myocardial in-farction. Br. Med. J. (1989) 298:779–782.
   PubMed Web of Science ®Google Scholar
• MACKENZIE RS, MILLARD HD: Interrelated effects of dia-betes, arteriosclerosis and calculus on alveolar bone loss. J. Am. Dent. Assoc. (1963) 66:192–198.
   Google Scholar
• SYRJANEN J, PELTOLA J, VALTONEN V etal.: Dental infec-tions in association with cerebral infarction in young and middle-aged men. J. Int. Med. (1989) 225:179–184.
   Google Scholar
• VAN ES RJJ: Smokers neglect their teeth. Br. Med. J. (1993) 306:1195.
   Web of Science ®Google Scholar
• LOWE GDO: Roles of white cells and fibrinogen. Br. Med. J. (1993) 306:1196.
   Web of Science ®Google Scholar
• KWEIDER M, LOWE GDO, MURRAY GD, KINANE DF, MCGOWAN DA: Dental disease, fibrinogen, and whitev © Ashley Publications Ltd. All rights reserved.Exp. Opin. Invest. Drugs (1998) 7(5) cell count: links with myocardial infarction? Scot. Med. J. (1993) 38:73–74.
   Google Scholar
• MATTILA K, RASI V, NIEMINEN M et at: von Willebrand factor antigen and dental infection. Thromb. Res. (1989) 56:325–329.
   PubMedGoogle Scholar
• HERZBERG MC, MEYER MW: Effects of oral flora on platelets: possible consequences in cardiovascular dis-ease. J. Periodontol (1996) 67:1138–1142.
   PubMed Web of Science ®Google Scholar
• KWEIDER M, LOWE GDO, MURRAY GD, KINANE DF, MCGOWAN DA: Dental disease, fibrinogen and white cell count: links with myocardial infarction? Scot. Med. J. (1993) 38:73–74.
   Google Scholar
• FUCHS D, REIBNEGGER G, WACHTER H: Biological mechanisms for link. Br. Med. J. (1993) 306:1196.
   PubMed Web of Science ®Google Scholar
• LOWE GDO, KWEIDER M, MURRAY GD, KINANE D, MCGOWAN DA: Fibrinogen and dental disease - a coro-nary risk factor. In: Fibrinogen: A New' Cardiovascular Risk Factor. Ernest E, Koenig W, Lowe GDO, Meade TW (Eds.), Blackwell-MZV, Vienna (1992):336–337.
   Google Scholar
• NIETO FJ, ADAM E, SORLIE P et al: A cohort study of cy-tomegalovirus infection as a risk factor for carotid intimal-medial thickening, a measure of subclinical atherosclerosis. Circulation (1996) 94:922–927.
   PubMed Web of Science ®Google Scholar
• VIIK-KAJANDER M, ROIVAINEN M, MANNINEN V, HOVI T, MANTTARI M: Herpes virus infections and the risk of myocardial infarction and coronary death. Circulation (1997) 96(Suppl. D:1–374.
   Google Scholar
• MANGIAVACCHI M, FRIGEIRO M, GRONDA E et al: Acute rejection and cytomegalovirus infection: correlation with cardiac allograft vasculopathy. Transplant. Proc. (1995) 27:1960–1962.
   PubMed Web of Science ®Google Scholar
• ZHOU YF, LEON MB, WACLAWIW MA et al.: Association between prior cytomegalovirus infection and the risk of restenosis after coronary atherectomy. New Engl. J. Med. (1996) 335:624–630.
   PubMed Web of Science ®Google Scholar
• MCDONALD K, RECTOR TS, BRAUNLIN EA, KUBO SH, OLIVARI MT: Association of coronary artery disease in cardiac transplant recipients with cytomegalovirus in-fection. Am. J. Cardiol (1989) 64:359–362.
   PubMed Web of Science ®Google Scholar
• ADAM E, MELNICK JL, PROBTSFIELD JL et al: High levels of cytomegalovirus antibody in patients requiring vas-cular surgery for atherosclerosis. Lancet (1987) 2:291–293.
   PubMed Web of Science ®Google Scholar
• CAMERON DE, GREENE PS, ALEJO SM et al.: Postopera-tive cytomegalovirus infection and older donor age predispose to coronary atherosclerosis after heart transplanation. Circulation (1989) 80 (Suppl. 2)11–526.
   Google Scholar
• MCGIFFIN DC, SAVUNEN T, KIRKLIN JK et al.: Cardiac transplant coronary artery disease: a multivariable analysis of pretransplanation risk factors for disease development and morbid events. J. Thorac. Cardiovasc. Surg. (1995) 109:1081–1089.
   PubMed Web of Science ®Google Scholar
• GRATTAN MT, MORENO-CABRAL CE, STARNES VA et al.: Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis. JAMA (1989) 261:3561–3566.
   PubMed Web of Science ®Google Scholar
• GAO SZ, HUNT SA, SCHROEDER JS et al: Early develop-ment of accelerated graft coronary artery disease: risk factors and course. JACC (1996) 28:673–679.
   Google Scholar
• THOMAS W, LELE S, ADLER S et al: Lack of evidence for a relationship between cytomegalovirus status in coro-nary angiographic restenosis. Circulation (1997) 96(Suppl. D:1–650.
   Google Scholar
• MUHLESTEIN JB, CARLQUIST JF, HORNE BD et al.: No as-sociation between prior cytomegalovirus infection and the risk of clinical restenosis after percutaneous coronary interventions. Circulation (1997) 96\(Suppl. 6):1–650.
   Google Scholar
• BALK AHMM, VAN DER LINDEN M, WEIMAR W et al: Is there a relation between transplant coronary artery disease and the occurrence of CMV infection? J. Heart Lung Transplant. (1991) 10:188.
   Google Scholar
• EVERETT JP, HERSHBERGER RE, NORMAN DJ et al.: Pro-longed cytomegalovirus infection with viremia is asso-ciated with development of cardiac graft vasculopathy. J. Heart Lung Transplant. (1992) 11:S133–S137.
   Google Scholar
• LOEBE M, SCHULLER S, SPIEGELSBERGER S et al.: Cytomegalievirus-Infektion und Koronarsklerose mach Hertztransplantation. Dtsch. Med. Wschr. (1990) 115:1266–1269.
   PubMedGoogle Scholar
• LOEBE M, SCHULER S, ZAIS 0 et al.: Role of cytomega-lovirus infection in the development of coronary ar-tery disease in the transplanted heart. J. Heart Transplant. (1990) 9:707–711.
   Google Scholar
• SORLIE PD, ADAMS EA, MELNICK SL et al: Cytomegalovi-rus/herpesvirus and carotid atherosclerosis: the ARIC study. J. Med. Virol. (1994) 42:33–37.
   PubMed Web of Science ®Google Scholar
• DUMMER S, LEE A, BREINIG MK et al: Investigation of cy-tomegalovirus infection as a risk factor for coronary atherosclerosis in the explanted patients undergoing heart transplantation. J. Med. Vim]. (1996) 44:305–309.
   Web of Science ®Google Scholar
• COUR MI, LOPEZ DE ATALAYA FJ et al: Lack of serologi-cal association between herpesvirus and atherosclero-sis. Lancet (1989) 1:279.
   PubMed Web of Science ®Google Scholar
• MUSIANI M, ZERBINI ML, MUSCARI A et al: Antibody pat-terns against cytomegalovirus and Epstein-Barr virus in human atherosclerosis. Microbiological (1990) 13:35–41.
   PubMedGoogle Scholar
• POBER JS: Immunologic basis of cardiovascular dis-ease: an overview. Clin. Cardiol (1991) 14:1–2.
   Google Scholar
• KANER RJ, HADAR DP: Viral activation of thrombo-atherosclerosis. In: Atherosclerosis and Coronary Artery Disease. Fuster V, Ross R, Topol EJ (Eds.), Lippincott-Raven Publishers, Philadelphia (1996):569–584.
   Google Scholar
• LARSSON PA, EDSTROM S, WESTIN T et al.: Reactivity against herpes simplex virus in patients with head and neck cancer. Int. J. Cancer (1991) 49:14–18.
   PubMed Web of Science ®Google Scholar
• HAVLIK RJ, BLACKWELDER WC, KASLOW R, CASTELLI W: Unlikely association between clinically apparent her-pesvirus infection and coronary incidence at older ages. Arteriosclerosis (1989) 9:877-880. © Ashley Publications Ltd. All rights reserved.Exp. Opin. Invest. Drugs (1998) 7(5)
   Google Scholar
• YE D, NICHOLS TC, DEHMER GJ et al: Absence of human herpesvirus 8 genomes in coronary atherosclerosis in immunocompetent patients. Am. J. Cardiol. (1997) 79:1245–1247.
   PubMed Web of Science ®Google Scholar
• NIETO FJ, SORLIE P, COMSTOCK GW et al.: Cytomega-lovirus infection, lipoprotein(a), and hypercoagula-bility: an atherogenic link? Arterioscler. Thromb. Vasc. Biol. (1997) 17:1780–1785.
   PubMed Web of Science ®Google Scholar
• FERNANDO S, BOOTH J, BORISKIN Y et al.: Association of cytomegalovirus infection with post-transplantation cardiac rejection as studied using the polymerase chain reaction. J. Med. Vim]. (1994) 42:396–404.
   PubMed Web of Science ®Google Scholar
• MELNICK JL, HU CH, BUREK J, ADAM E, DEBAKEY ME: Cy-tomegalovirus DNA in arterial walls of patients with atherosclerosis. J. Med. Virol. (1994) 42:170–174.
   PubMed Web of Science ®Google Scholar
• GYORKEY F, MELNICK JL, GUINN GA, GYORKEY P, DE-BAKEY ME: Herpesviridae in the endothelial and smooth muscle cells of the proximal aorta in arterio-sclerotic patients. Exp. Mol. Pathol. (1984) 40:328–339.
   PubMed Web of Science ®Google Scholar
• HENDRIX MGR, DAEMEN M, BRUGGEMAN CA: Cy-tomegalovirus nucleic acid distribution with the hu-man vascular tree. Am. J. Pathol. (1991) 138:563–567.
   PubMed Web of Science ®Google Scholar
• HENDRIX MGR, DORMANS PHJ, KITSLAAR P, BOSMAN F, BRUGGEMAN CA: The presence of cytomegalovirus nu-cleic acids in arterial walls of atherosclerotic and nonatherosclerotic patients. Am. J. Pathol. (1989) 134:1151–1157.
   PubMed Web of Science ®Google Scholar
• GUILIZIA JM, KANDOLF R, KENDALL TJ et al.: Infre-quency of cytomegalovirus genome in coronary arte-riopathy of human heart allografts. Am. J. Pathol. (1995) 147:461–475.
   PubMed Web of Science ®Google Scholar
• PETRIE BL, MELNICK JL, ADAM E et al.: Nucleic acid se-quences of cytomegalovirus in cells cultured from hu-man arterial tissue. J. Infect. Dis. (1987) 155:158–159.
   PubMed Web of Science ®Google Scholar
• CHEN R, WU L, YANG Y: Detection of HCMV DNA in vas-cular plaques of atherosclerosis by in situ hybridisa-tion. Nall Med. J. China (1995) 75:592–594.
   Google Scholar
• YAMASHIROYA HM, GHOSH L, YANG R, ROBERTSON AL: Herpesviridae in the coronary arteries and aorta of young trauma victims. Am. J. Pathol. (1988) 130:71–79.
   PubMed Web of Science ®Google Scholar
• MELNICK JL, DREESMAN GR, MCCOLLUM CH et al.: Cy-tomegalovirus antigen within human arterial smooth muscle cells. Lancet (1983) ii:644–647.
   Google Scholar
• HENDRIX MGR, SALIMNS MMM, VAN BOVEN CPA, BRUG-GEMAN CA: High prevalence of latently present cy-tomegalovirus in arterial walls of patients suffering from grade III atherosclerosis. Am. J. Pathol (1990) 136:23–28.
   PubMed Web of Science ®Google Scholar
• SPEIR E, MODALI R, HUANG ES et al: Potential role of hu-man cytomegalovirus and p53 interaction in coronary restenosis. Science (1994) 265:391–394.
   PubMed Web of Science ®Google Scholar
• PAULTEEO P, PISONI G, BOSCHETTO R et al: Human cy-tomegalovirus and restenosis of the internal carotid artery. Stroke (1996) 27:1669–1671.
   PubMed Web of Science ®Google Scholar
• WU TC, HRUBAN RH, AMBINDER RF et al.: Demonstra-tion of cytomegalovirus nucleic acids in the coronary arteries of transplanted hearts. Am. J. Pathol (1992) 140:739–747.
   PubMed Web of Science ®Google Scholar
• BENDITT EP, BARRETT T, MCDOUGALL JK: Viruses in the etiology of atherosclerosis. Proc. Natl. Acad. Sci USA (1983) 80:6386–6389.
   PubMed Web of Science ®Google Scholar
• PETRIE BL, ADAM E, MELNICK JL: Association of herpes-virus/cytomegalovirus infections with human athero-sclerosis. Prog. Med. Virol. (1988) 35:21–42.
   PubMedGoogle Scholar
• BRUGGEMAN CA, VAN DAM-MIERAS MCE: The possible role of cytomegalovirus in atherogenesis. In: Progress in Medical Virology. Melnick JL, (Ed.), Karger, Basel (199 1) :1–26.
   Google Scholar
• BENDITT EP, BENDITT JM: Evidence for a monoclonal origin of human atherosclerotic plaques. Proc. Natl. Acad. Sci. USA (1973) 70:1753–1756.
   PubMed Web of Science ®Google Scholar
• •Remarkable observation that has still not been properly explained.
   Google Scholar
• KOL A, SPERTI G, SHANI J et al.: Cytomegalovirus repli-cation is not a cause of instability in unstable angina. Circulation (1995) 91:1910–1913.
   PubMed Web of Science ®Google Scholar
• MALATY HM, ENGSTRAND L, PEDERSEN NL, GRAHAM DY: Helicobacter pylori: genetic and environmental influences. A study of twins. Ann. Intern. Med. (1994) 120:982–986.
   PubMed Web of Science ®Google Scholar
• LOGAN RPH, BERG DE: Genetic diveristy of Helicobac-ter pylori. Lancet (1996) 348:1462–1463.
   PubMed Web of Science ®Google Scholar
• MAASS M, GIEFFERS J: Cardiovascular disease risk from prior Chlamydia pneumoniae infection can be related to certain antigens recognized in the immunoblot pro-file. J. Infect. (1997) 35:171–176.
   PubMed Web of Science ®Google Scholar
• PARISH S, COLLINS R, PETO R et al.: Cigarette smoking tar yields, and non-fatal myocardial infarction: 14 000 cases and 32 000 controls in the United Kingdom. Br. Med. J. (1995) 311:471–477.
   PubMed Web of Science ®Google Scholar
• PUOLAKKAINEN M, KUO CC, SHOR A et al.: Serologic re-sponse to Chlamydia pneumoniae in adults with coro-nary arterial fatty streaks and flbrolipid plaques. J. Clin. Microbiol. (1993) 31:2212–2214.
   PubMed Web of Science ®Google Scholar
• MUHLESTEIN JB, CARLQUIST JF, HAMMOND EH et al: De-tection of Chlamydia pneumoniae bacteremia in pa-tients with symptomatic coronary atherosclerosis. 4th Int. Conf Macrolides (1998). Abstract 4.13.
   Google Scholar
• GUPTA S, LEATHAM EW, CARRINGTON D et al.: Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocar-dial infarction. Circulation (1997) 96:404–407.
   PubMed Web of Science ®Google Scholar
• GURFINKEL E, BOZOVICH G, DAROCA A, BECK A, MAUT-NER B: Randomised trial of roxithromycin in non-Q-wave coronary syndromes: ROXIS pilot study. Lancet (1997) 350:404–407.
   PubMed Web of Science ®Google Scholar
• PETO R: Clinical trial methodology. Biomedicine Special Issue (1978) 24:24–38.
   Google Scholar
• RIDGWAY GI, MUMTAZ G, FENELON L The in vitro activ- ity of clarithromycin and other macrolides against the © Ashley Publications Ltd. All rights reserved.Exp. Opin. Invest. Drugs (1998) 7(5) type strain of Chlamydia pneumoniae (TW AR). J. Anti-microb. Chemother. (1991) 27:43–46.
   Google Scholar
• CHIRGWIN K, ROBLIN PM, HAMMERSCHLAG MR: In vitro susceptibilities of Chlamydia pneumoniae (Chlamy-dia sp. strain TWAR). Antimicrob. Agents Chemother. (1989) 339:1634–1635.
   Google Scholar
• WELSH LE, GAYDOS CA, QUINN TC: In vitro evaluation of azithromycin, erythromycin and tetracycline against 15 clinical isolates of Chlamydia trachomatis and Chlamydia pneumoniae. Am. Soc. Microbic)]. (1990:366. Abstract.
   Google Scholar